Zheng Y - Search Results

1

CLOUDING OF INTRAOCULAR SILICONE OIL IN THE ABSENCE OF EMULSIFICATION.

Zheng Y, de Vries JW, Herrmann A, Bartz-Schmidt KU, Dammeier S, Spitzer MS. Zheng Y, et al. Retin Cases Brief Rep. 2023 Mar 1;17(2):144-151. doi: 10.1097/ICB.0000000000001123. Retin Cases Brief Rep. 2023. PMID: 33492074

2

Analysis of retinal detachment resulted from post-operative endophthalmitis treated with 23G pars Plana Vitrectomy.

Zheng Y, Casagrande M, Dimopoulos S, Bartz-Schmidt KU, Spitzer MS, Skevas C. Zheng Y, et al. BMC Ophthalmol. 2021 Dec 1;21(1):414. doi: 10.1186/s12886-021-02175-z. BMC Ophthalmol. 2021. PMID: 34852777 Free PMC article.

3

Correction to: Analysis of retinal detachment resulted from post-operative endophthalmitis treated with 23G pars Plana Vitrectomy.

Zheng Y, Casagrande M, Dimopoulos S, Bartz-Schmidt KU, Spitzer MS, Skevas C. Zheng Y, et al. BMC Ophthalmol. 2022 Feb 8;22(1):61. doi: 10.1186/s12886-022-02258-5. BMC Ophthalmol. 2022. PMID: 35135502 Free PMC article. No abstract available.

4

Inverted internal limiting membrane insertion combined with air tamponade in the treatment of macular hole retinal detachment in high myopia: study protocol for a randomized controlled clinical trial.

Zheng Y, Kang M, Wang H, Liu H, Sun T, Sun X, Wang F. Zheng Y, et al. Trials. 2018 Aug 30;19(1):469. doi: 10.1186/s13063-018-2833-y. Trials. 2018. PMID: 30165894 Free PMC article.

5

Comparison of treatment outcomes of 360° intraoperative laser retinopexy and focal laser retinopexy with pars plans vitrectomy in patients with primary rhegmatogenous retinal detachment.

Zheng Y, Schindler P, Druchkiv V, Schulz J, Spitzer SM, Skevas C. Zheng Y, et al. BMC Ophthalmol. 2023 Feb 21;23(1):73. doi: 10.1186/s12886-023-02812-9. BMC Ophthalmol. 2023. PMID: 36809995 Free PMC article.

6

Novel peptide derived from IGF-2 displays anti-angiogenic activity in vitro and inhibits retinal angiogenesis in a model of oxygen-induced retinopathy.

Zheng Y, Sun Q, Xu X, Wang W. Zheng Y, et al. Clin Exp Ophthalmol. 2020 Dec;48(9):1261-1275. doi: 10.1111/ceo.13864. Epub 2020 Oct 19. Clin Exp Ophthalmol. 2020. PMID: 33026147

7

Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.

Zheng Y, Gu Q, Xu X. Zheng Y, et al. Acta Ophthalmol. 2012 Nov;90(7):e512-23. doi: 10.1111/j.1755-3768.2012.02476.x. Epub 2012 Sep 20. Acta Ophthalmol. 2012. PMID: 22994140 Free article.

8

Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.

Lu Y, Zheng Y, Ai J, Xu X. Lu Y, et al. Among authors: zheng y. Discov Med. 2016 May;21(117):349-61. Discov Med. 2016. PMID: 27355331 Free article.

9

A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo.

Xu Y, Zhao H, Zheng Y, Gu Q, Ma J, Xu X. Xu Y, et al. Among authors: zheng y. Mol Vis. 2010 Oct 7;16:1982-95. Mol Vis. 2010. PMID: 21031024 Free PMC article.

10

A novel microdeletion of 517 kb downstream of the PAX6 gene in a Chinese family with congenital aniridia.

Li Y, Chen J, Zheng Y, Chen Z, Wang T, Sun Q, Wan X, Liu H, Sun X. Li Y, et al. Among authors: zheng y. BMC Ophthalmol. 2023 Sep 26;23(1):393. doi: 10.1186/s12886-023-03147-1. BMC Ophthalmol. 2023. PMID: 37752489 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,594 results

Search Page

Filters